Prefilled Syringes Market Size, Share and Growth Forecast 2025-2033

 

Market Overview:

The Prefilled Syringes Market is experiencing rapid expansion, driven by Rising Demand for Injectable Drugs, Growing Preferences for Safety and Convenience and Advancements in Prefilled Syringe Technology. According to IMARC Group's latest research publication, "Prefilled Syringes Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025–2033", The global prefilled syringes market size was valued at USD 8.16 Billion in 2024. The market is projected to reach USD 15.75 Billion by 2033, exhibiting a CAGR of 7.58% from 2025-2033.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

Grab a sample PDF of this report: https://www.imarcgroup.com/prefilled-syringes-market/requestsample

Our Report Includes:

• Market Dynamics

• Market Trends and Outlook

• Competitive Analysis

• Industry Segmentation

• Strategic Recommendations

Growth Factors in the Prefilled Syringes Industry:

• Rising Demand for Injectable Drugs

Escalating demand for injectable drugs, especially biologics, vaccines, and therapeutic agents, is offering a favorable prefilled syringes market outlook. Injectable medications are often preferred for their fast-acting effects, crucial for chronic diseases, cancers, and autoimmune conditions, which require precise, controlled dosages. In line with this, prefilled syringes offer a convenient, ready-to-use solution that reduces the risks of dosage errors, contamination, and preparation time. Furthermore, the rising prevalence of chronic diseases and increased focus on patient-centric healthcare are driving the adoption of injectable drug formats, encouraging pharmaceutical companies to employ prefilled syringes for efficiency and safety. According to a 2024 report by the United States Centers for Disease Control and Prevention (CDC), around 129 Million individuals in the United States experienced at least one major chronic disease. Additionally, the US National Institutes of Health (NIH) estimated that by 2030, the global economic burden of chronic diseases is expected to reach USD 47 Trillion.

• Growing Preferences for Safety and Convenience

Rising preferences for patient care and convenience are among the major prefilled syringes market trends. Healthcare providers and patients prefer prefilled syringes due to their enhanced safety features, including reduced contamination risks and accurate dosing. This format minimizes the risk of needlestick injuries, cross-contamination, and other hazards associated with traditional vials and syringes. In addition to this, with the growing emphasis on home healthcare and self-administration, prefilled syringes are becoming popular among patients, as they simplify the process, supporting ease of use and minimizing potential health risks. In 2024, the global home healthcare market reached USD 424.0 Billion, as per industry reports. The market is set to attain USD 816.4 Billion by 2033, growing at a CAGR of 7.48% during 2025-2033. This, in turn, is contributing to the market growth significantly.

• Advancements in Prefilled Syringe Technology

Innovations in materials like the use of glass alternatives and ultra-thin needles are improving syringe durability and patient comfort. The development of safety-engineered devices and auto-disable syringes further ensures accurate dosing and prevents accidental misuse. Moreover, advancements in prefilled syringe manufacturing, such as automated filling and sealing processes, are enhancing product quality and scalability. For instance, in November 2024, Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO) based in the US, revealed an investment of USD 3.6 Million to refine its prefilled syringe solutions, focusing on fill-finish processes, automated visual inspection, and advanced labeling. These technological improvements are essential as the pharmaceutical industry is shifting towards complex biologics that require specialized, sterile packaging, making advanced prefilled syringes the preferred choice for numerous therapeutic applications.

Key Trends in the Prefilled Syringes Market

• Shift Toward Self-Administration and Home Healthcare

The increasing trend toward self-administration and home healthcare is significantly driving market growth, as patients with chronic conditions prefer the convenience of at-home treatment. Prefilled syringes enable patients to self-inject medications without requiring professional assistance, improving treatment adherence and quality of life. The growing adoption of biologics and biosimilars that require injectable delivery is particularly supporting this trend, as prefilled formats offer ease of use with pre-measured doses and simplified administration protocols.

• Focus on Reducing Medication Errors and Contamination

Healthcare systems are prioritizing patient safety by adopting prefilled syringes that minimize medication errors and contamination risks. Traditional vial-based systems require multiple handling steps that increase the likelihood of dosing mistakes and microbial contamination. Prefilled syringes eliminate these risks by providing pre-measured, sterile, single-use formats that ensure accurate dosing and maintain drug integrity. This safety emphasis is particularly critical in hospital settings, emergency care, and for vulnerable patient populations requiring precise medication delivery.

• Expansion of Biologic and Vaccine Applications

The rapid growth of biologic therapies and vaccination programs is creating substantial demand for prefilled syringes optimized for sensitive formulations. Biologics, including monoclonal antibodies and protein-based drugs, require specialized delivery systems that maintain drug stability and minimize protein aggregation. Prefilled syringes with advanced coatings, materials compatibility, and precise volume control are becoming essential for biologic drug delivery. Additionally, global vaccination campaigns and pandemic preparedness initiatives are accelerating adoption of prefilled vaccine formats for efficient mass immunization programs.

Leading Companies Operating in the Global Prefilled Syringes Industry:

• B. Braun SE

• Becton, Dickinson and Company

• Catalent Inc.

• Fresenius Kabi AG

• Gerresheimer AG

• NIPRO Corporation

• SCHOTT Pharma AG & Co. KGaA

• Stevanato Group

• Taisei Kako Co., Ltd.

• West Pharmaceutical Services, Inc.

Prefilled Syringes Market Report Segmentation:

Breakup by Design:

• Single-chamber Prefilled Syringes

• Dual-chamber Prefilled Syringes

• Customized Prefilled Syringes

Single-chamber prefilled syringes held 47.0% of the market share in 2024 as they are preferred due to their simplicity, cost-effectiveness, and wide usage across various therapeutic areas.

Breakup by Material:

• Glass Prefilled Syringes

• Plastic Prefilled Syringes

Glass prefilled syringes account for 72.5% of the market share due to their excellent barrier properties, chemical resistance, and long-standing reliability with a wide range of drugs.

Breakup by Closing System:

• Staked Needle System

• Luer Cone System

• Luer Lock Form System

Staked needle system holds 43.6% of the market share as it is preferred due to its convenience, ease of use, and reduced risk of contamination with the needle permanently attached to the syringe.

Breakup by Application:

• Diabetes

• Anaphylaxis

• Rheumatoid Arthritis

• Oncology

• Others

Diabetes holds a significant share due to the growing number of patients who require regular insulin injections, with prefilled syringes offering convenient, accurate, and sterile method for insulin delivery.

Breakup by End User:

• Hospitals

• Clinics

• Others

Hospitals account for 59.3% of the market share as they handle large volume of patients daily, with prefilled syringes supporting efficient workflows by offering ready-to-use solutions that save time for healthcare professionals.

Breakup by Region:

• Europe

• North America (United States, Canada)

• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

• Latin America (Brazil, Mexico, Others)

• Middle East and Africa

Europe currently dominates the market, holding a market share of 34.6% in 2024, noted for its strong healthcare infrastructure, advanced manufacturing capabilities, and high regulatory standards.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1–201971–6302